Market closedNon-fractional
Cronos Group/CRON
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Cronos Group
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Ticker
CRON
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Toronto, Canada
Employees
356
Website
www.thecronosgroup.com
Cronos Group Metrics
BasicAdvanced
$1.2B
Market cap
-
P/E ratio
-$0.15
EPS
1.02
Beta
-
Dividend rate
Price and volume
Market cap
$1.2B
Beta
1.02
Financial strength
Current ratio
28.194
Quick ratio
26.339
Long term debt to equity
0.122
Total debt to equity
0.211
Management effectiveness
Return on assets (TTM)
-4.02%
Return on equity (TTM)
-4.99%
Valuation
Price to revenue (TTM)
9.3
Price to book
1.1
Price to tangible book (TTM)
1.12
Price to free cash flow (TTM)
-441.72
Growth
Revenue change (TTM)
11.37%
Earnings per share change (TTM)
-64.13%
3-year revenue growth
22.27%
3-year earnings per share growth
-44.48%
What the Analysts think about Cronos Group
Analyst Ratings
Majority rating from 7 analysts.
Cronos Group Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$25M
5.44%
Net income
-$2.2M
-95.08%
Profit margin
-8.73%
-95.33%
Cronos Group Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.01
-
-$0.05
-$0.01
-
Expected
-$0.03
-$0.02
-$0.02
-$0.02
-$0.00
Surprise
-67.73%
-
150.00%
-33.33%
-
Cronos Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cronos Group stock?
Cronos Group (CRON) has a market cap of $1.2B as of July 05, 2024.
What is the P/E ratio for Cronos Group stock?
The price to earnings (P/E) ratio for Cronos Group (CRON) stock is 0 as of July 05, 2024.
Does Cronos Group stock pay dividends?
No, Cronos Group (CRON) stock does not pay dividends to its shareholders as of July 05, 2024.
When is the next Cronos Group dividend payment date?
Cronos Group (CRON) stock does not pay dividends to its shareholders.
What is the beta indicator for Cronos Group?
Cronos Group (CRON) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Cronos Group stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.